4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid, 95.0%, 10g

4-hydroxy-N,N-dimethylbenzamide, 95.0%, 5g

6-Bromonicotinic Acid>98.0%(GC)(T)25g

Formamida, mínimo 99,5 %, pa, ACS, 2,5 l, envase de vidrio

Methyl 4-((4-methylpiperazin-1-yl)methyl)benzoate, 95.0%, 1g

3-Cyano-4-propoxybenzoic acid, 98%, 100mg

2-Hydroxy-4-(trifluoromethyl)aniline, 97.0%, 25g

(1S,2R)-rel-2-[(tert-butoxy)carbonyl]cyclopropane-1-carboxylic acid, 95.0%, 1g

5-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95%, 10g

5-(Piperazin-1-yl)-1,6-naphthyridine trihydrochloride, 90.0%, 5g

7-HYDROXYSPIRO[CHROMAN-2,4'-PIPERIDIN]-4-ONE HCL, 95.0%, 1g

3-Chloro-4-(3-pyridin-2-yl-ureido)benzenesulfonylchloride hydrogen sulfate, 1g

(R)-1-Cyclobutylpyrrolidin-3-amine dihydrochloride, 95.0%, 1g